Virosomes as carriers for combined vaccines

Vaccine
B MengiardiR Glück

Abstract

Immunopotentiating reconstituted influenza virosomes (IRIV) are liposomes which carry the two glycoproteins of the influenza virus on their surface. A hepatitis A vaccine using IRIV as carrier has very good immunogenicity and is well tolerated. The objective of this study was to produce a fivefold combined vaccine against hepatitis A and B, diphtheria, tetanus and influenza A/B, and to show that in principle IRIVs can serve as carriers for multiple antigens which have good immunogenicity and are well tolerated. A total of four studies were carried out. Either the combined vaccine or the corresponding adequately tested alum-adsorbed single vaccines were tested for reactogenicity and immunogenicity in young adults. A hepatitis A and B combination on an IRIV base showed the same immunogenicity and toleration as the single vaccines. However, with the simultaneous coupling of all five vaccines on the same IRIV or the binding of Di-Te and HAV on different IRIVs there was a suppression of the humoral immune response against HAV (p = 0.03). The possibility that epitope-specific suppression had occurred could be ruled out. The suppression of the response against HAV could be circumvented by halving the quantity of Di-Te antigen in the c...Continue Reading

References

Mar 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·T YasudaS C Kinsky
Dec 11, 1992·Deutsche medizinische Wochenschrift·J P Schröder, W D Kuhlmann
Jan 1, 1985·International Archives of Allergy and Applied Immunology·M F Maceda SoaresI Mota
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·B P BabbittP M Allen
Jan 1, 1985·International Archives of Allergy and Applied Immunology·L Polak
Oct 27, 1967·Science·J Radovich, D W Talmage
Jun 1, 1982·The Journal of Experimental Medicine·L A Herzenberg, T Tokuhisa
Oct 1, 1984·The Journal of Experimental Medicine·K L RockA K Abbas
Feb 5, 1994·Lancet·L LoutanR Glück
Jun 1, 1965·Proceedings of the Society for Experimental Biology and Medicine·H ASHLEY, Z OVARY

❮ Previous
Next ❯

Citations

Dec 31, 2003·International Journal of Pharmaceutics·M MuñozI Haro
Jan 27, 2004·Vaccine·Maria Grazia CusiPierpaolo Correale
Dec 14, 2001·Molecular Immunology·O B EnglerA Cerny
Dec 14, 2001·Molecular Immunology·I P HunzikerA Cerny
Nov 18, 2000·Progress in Lipid Research·D C DrummondJ Leroux
Jul 31, 1998·Immunology and Cell Biology·J Kovarik, C A Siegrist
Apr 1, 2011·International Journal of Pharmaceutical Investigation·Ch SarojaShyamala Bhaskaran
Aug 12, 1999·Biochemical and Biophysical Research Communications·A HayashiT Mayumi
Apr 4, 2013·Molecular Pharmaceutics·Gaëlle VacherGerrit Borchard
Dec 29, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kar Perng LowKhee Chee Soo
Jul 11, 2008·Expert Opinion on Biological Therapy·Patrick A Bovier
Jun 15, 2011·Influenza and Other Respiratory Viruses·Jessica C SeidmanMark A Miller
Oct 11, 2008·Expert Review of Vaccines·Patrick A Bovier
Aug 29, 2003·Expert Opinion on Biological Therapy·Elisabetta FrancoMassimo Maurici
Jul 23, 2004·Expert Opinion on Biological Therapy·Reinhard GlückIan C Metcalfe
Aug 6, 2003·Expert Review of Vaccines·Christian MoserJean-François Viret
Jul 1, 2001·Medical Journal, Armed Forces India·C G WilsonK Nagendra
Feb 13, 2016·Expert Opinion on Drug Delivery·Carl R AlvingMangala Rao
Nov 26, 2010·Expert Review of Vaccines·Antu K Dey, Indresh K Srivastava
Jun 28, 2015·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Viktoriya SokolovaMatthias Epple

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.